Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence

BACKGROUND: The role of sorafenib in patients with hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) has been rarely studied. The aim of this study was to evaluate the efficacy of sorafenib in post-LT era. METHODS: Consecutive patients with post-transplant HCC recurrence not...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Korean Med Sci
Autors principals: Kang, Seong Hee, Cho, Hyeki, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Kim, Yoon Jun, Yi, Nam-Joon, Lee, Kwang-Woong, Suh, Kyung-Suk, Yoon, Jung-Hwan
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209769/
https://ncbi.nlm.nih.gov/pubmed/30402048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2018.33.e283
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars